K
Kathryn Moore
Publications - 9
Citations - 384
Kathryn Moore is an academic researcher. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 1, co-authored 1 publications receiving 5 citations.
Papers
More filters
letters-and-commentsDOI
SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination
Rolando Pajon,Nicole A. Doria-Rose,Xiaoying Shen,R. Schmidt,Sijy O'Dell,Charlene McDanal,Wen Yu Feng,Jin Tong,Amanda Eaton,Maha Maglinao,Haili Tang,Kelly E. Manning,Venkata Viswanadh Edara,Lilin Lai,Madison Ellis,Kathryn Moore,Katharine Floyd,Stephanie L. Foster,Christine M. Posavad,Robert L. Atmar,Kirsten E. Lyke,Tongqing Zhou,Lingshu Wang,Yi Zhang,Martin R. Gaudinski,W. Black,Ingelise J. Gordon,M. Guech,Julie E. Ledgerwood,John Misasi,Alicia T. Widge,Nancy J. Sullivan,Paul Roberts,John H. Beigel,Bette T. Korber,Lindsey R. Baden,Hana M. El Sahly,Spyros Chalkias,Honghong Zhou,Jing Feng,B. Girard,R. Das,Anne Aunins,Darin K. Edwards,Mehul S. Suthar,John R. Mascola,David C. Montefiori +46 more
Journal ArticleDOI
mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 omicron variant
Venkata Viswanadh Edara,Kelly E. Manning,Madison Ellis,Lilin Lai,Kathryn Moore,Stephanie L. Foster,Katharine Floyd,Meredith E. Davis-Gardner,Grace Mantus,Lindsay E. Nyhoff,Sarah Bechnak,Ghina Alaaeddine,Amal Naji,Hady Samaha,Matthew Lee,Laurel Bristow,Matthew Gagne,Jesmine Roberts-Torres,Amy R. Henry,Sucheta Godbole,Arash Grakoui,Marybeth Saxton,Anne Piantadosi,Jesse J. Waggoner,Daniel C. Douek,Nadine Rouphael,Jens Wrammert,Mehul S. Suthar +27 more
TL;DR: BadBaden et al. as discussed by the authors used serum from mRNA-vaccinated individuals to measure neutralization activity against omicron in a live-virus assay, and they showed that a third dose is required to provide robust neutralizing antibody responses against the Omicron variant.
Journal ArticleDOI
Contrasting behavior between the three human monocyte subsets in dengue pathophysiology
Deepti Maheshwari,Keshav K Saini,Prabhat Singh,Mohit Singla,Kaustuv Nayak,Charu Aggarwal,Yadya M Chawla,Prashant Kumar Bajpai,Manpreet Kaur,Sivaram Gunisetty,Christiane S. Eberhardt,Rajni Nyodu,Kathryn Moore,Mehul S. Suthar,Guruprasad R. Medigeshi,Evan Anderson,Rakesh Lodha,Sushil K. Kabra,Raf Ahmed,Anmol Chandele,Kaja Murali-Krishna +20 more
TL;DR: In this paper , the authors provided a detailed transcriptional analysis of the three human monocyte subsets in healthy children and in children with dengue febrile illness, and found that the CD14+CD16high intermediate monocyte subset from dengUE patients highly upregulated key genes involved in mediating inflammation, endothelial dysfunction, vascular permeability, tissue extravasation, and clot prevention compared to healthy children.
Journal ArticleDOI
Rapid detection and characterization of SARS-CoV-2 omicron variant in a returning traveler.
Mary Elizabeth Sexton,Jesse J. Waggoner,L. R. Carmola,Phuong-Vi Nguyen,E. Wang,Dara Khosravi,Azmain Taz,Robert Arthur,Mit Patel,Venkata Viswanadh Edara,Stephanie L Foster,Kathryn Moore,Matthew Gagne,Jesmine Roberts-Torres,Amy R. Henry,Sucheta Godbole,Daniel C. Douek,Nadine Rouphael,Mehul S. Suthar,Anne Piantadosi +19 more
TL;DR: This case report describes the rapid detection of the SARS-CoV-2 omicron variant using a combination of targeted spike SNP PCR and viral genome sequencing.
Journal ArticleDOI
Antibody Response to COVID-19 mRNA Vaccine in Patients With Lung Cancer After Primary Immunization and Booster: Reactivity to the SARS-CoV-2 WT Virus and Omicron Variant
Rajesh M. Valanparambil,Jennifer W Carlisle,Susanne L. Linderman,Akil Akthar,Ralph L. Millett,Lilin Lai,Andres Chang,Ashley A. McCook-Veal,Jeffrey M. Switchenko,Tahseen H. Nasti,Manpreet Saini,Andreas Wieland,Kelly E. Manning,Madison Ellis,Kathryn Moore,Stephanie L. Foster,Katharine Floyd,Meredith E. Davis-Gardner,Venkata Viswanadh Edara,Mit Patel,Conor Steur,Ajay K. Nooka,Felicia Green,Margaret A. Johns,Fiona O'Brein,Uma Shanmugasundaram,Veronika I. Zarnitsyna,Hasan Ahmed,Lindsay E. Nyhoff,Grace Mantus,Michael Garett,Srilatha Edupuganti,Madhusmita Behra,Rustom Antia,Jens Wrammert,Mehul S. Suthar,Madhav V. Dhodapkar,Suresh S. Ramalingam,Rafi Ahmed +38 more
TL;DR: A subset of patients with NSCLC responded poorly to the SARS-CoV-2 mRNA vaccination and had low neutralizing antibodies to the B.1.529 Omicron variant, highlighting the concern for patients with cancer.